Invesaro

Stocks CGNT Financial statements

Financial statements

Cognyte Software Ltd. financial statements

Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data Cognyte Software Ltd. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2020FY2020FY2020FY2021FY2022FY2023FY2025FY2025
Revenue433457443474312313351400
Cost of revenue17716413313212098104110
Gross profit257293311342192215247290
Research and development100111129143140107108122
Selling, general and administrative137154163186154126144154
Selling and marketing10181.695107
General and administrative53.344.248.547.1
Operating expenses238266293331295233252276
Operating income18.727.318.311-103-18.1-5.1313.3
Interest expense0.50.480.190.21.60.020.10.19
Interest income3.173.511.350.180.771.92.472.03
Other non-operating income1.252.626.45-2.76.334.80.76-1.92
Pre-tax income19.929.924.78.26-97-13.3-4.3711.3
Income tax7.622.574.4118.513-1.612.866.73
Net income to minority interests3.597.186.114.634.183.934.825.25
Net income8.7320.214.2-14.9-114-15.6-12.1-0.64
EBITDA39.744.640.832.2-85.3-4.248.5325.2
EPS, basic0.130.310.22-0.22-1.68-0.22-0.17-0.01
EPS, diluted0.130.310.22-0.22-1.68-0.22-0.17-0.01
Shares, basic (weighted)65.865.865.866.667.970.171.872.9
Shares, diluted (weighted)65.865.865.866.667.970.171.872.9

Balance sheet

FY2020FY2020FY2020FY2021FY2022FY2023FY2025FY2025
Cash and equivalents24020178.615334.674.5113117
Short-term investments6.64.7110.417.50
Receivables180175179113113109123
Inventory14.914.514.425.324.61916.4
Other current assets3.482.070.760.60.940.810.83
Total current assets512350420252265286298
Property, plant and equipment41.637.630.825.924.428.329.1
Lease right-of-use assets34.232.12517.633.835.240.4
Goodwill147158158158126127126127
Intangible assets7.875.33.160.650.2604.38
Other non-current assets49.242.125.72019.118.916.2
Total assets805629665443472498521
Accounts payable43.441.636.720.720.925.226.9
Accrued liabilities85.991.799.878.375.886.794.6
Deferred revenue14412783.294.993.8107103
Short-term debt01000
Total current liabilities280299320194190219224
Lease liabilities24.424.117.210.42829.836.5
Other non-current liabilities17.49.210.811.77.617.689.37
Total liabilities350358366233257281292
Paid-in capital0317338355374395
Retained earnings0-14.9-129-145-157-157
Treasury stock0-5.28-26.7
Other comprehensive income-13.9-15.5-16.7-15.3-12.6-14-4.84
Shareholders' equity445258285194198198207
Minority interests10.612.91415.616.918.922.3
Total equity475455270299210215217229
Total liabilities and equity805629665443472498521
Shares outstanding65.867.268.87172.173.1

Cash flow statement

FY2020FY2020FY2020FY2021FY2022FY2023FY2025FY2025
Net income12.327.420.3-10.3-110-11.6-7.234.61
Depreciation and amortization2117.322.521.318.113.813.712
Stock-based compensation25.53127.432.925.212.21921.2
Deferred income tax95.6-2.25.860.05-3.2-1.36-1.96
Change in receivables-44.1-24.11.5-5.7259.212.410.6-6.27
Change in inventory-3.62-0.39-1.14-0.36-13.1-0.964.572.42
Change in payables-7.751.318.674.89-37.94.3314.310.5
Cash from operations53.767.271.32.63-3734.646.840.3
Capital expenditures-9.92-13.7-14.2-11.8-8.27-7.04-10.6-10.4
Acquisitions-3.81-18.700-4.28
Purchases of investments-57.7-29.1-48.6-59-55.2-58.700
Cash from investing-68.3-29.516.4-17.920.19.36-5.69-14.1
Cash from financing6.06-86-20658.7-103-2.45-7.95-24.8
Exchange rate effect-0.54-0.99-0.860.040.62-0.12-0.632.58
Net change in cash-9.09-49.3-11943.6-11941.432.53.97
Free cash flow43.853.557.1-9.13-45.327.536.229.9
Interest paid0.020.020.040.471.980.660.50.49
Income taxes paid7.69.621.268.2311.36.777.158.48

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $8.52 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin72.4%Gross profit / revenue.
Operating margin3.3%Operating income / revenue.
EBITDA margin6.3%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin2.8%Pre-tax income / revenue.
Net margin-0.2%Net income / revenue.
FCF margin7.5%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin10.1%Cash from operations / revenue.
Effective tax rate59.3%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)-0.3%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-0.1%Net income / average total assets.
Return on invested capital (ROIC)12.0%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue30.6%Research and development expense / revenue.
SG&A / revenue38.4%Selling, general and administrative expense / revenue.
Stock-based pay / revenue5.3%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue2.6%Capital expenditures / revenue.
D&A / revenue3.0%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y14.1%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y8.6%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y-2.0%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y17.3%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y14.7%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y-1.4%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income CAGR, 5y-6.2%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y196.0%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 5y-9.2%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-13.8%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y-10.8%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-17.3%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y-12.1%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y4.2%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y2.1%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-4.3%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y4.7%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y5.6%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-3.7%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y1.6%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y2.4%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y2.1%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.33xCurrent assets / current liabilities.
Quick ratio1.07x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.52x(Cash + short-term investments) / current liabilities.
Liabilities / assets56.1%Total liabilities / total assets.
Interest coverage68.4xOperating income / interest expense.
Working capital$74.2MCurrent assets - current liabilities.
Goodwill and intangibles / assets25.1%(Goodwill + intangible assets) / total assets.
Tangible book value$75.6MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.79xRevenue / average total assets.
Fixed asset turnover13.9xRevenue / average property, plant and equipment.
Inventory turnover6.23xCost of revenue / average inventory.
Days inventory59 days365 x average inventory / cost of revenue.
Receivables turnover3.45xRevenue / average receivables.
Days sales outstanding106 days365 x average receivables / revenue.
Days payables86 days365 x average accounts payable / cost of revenue.
Cash conversion cycle78 daysDays inventory + days sales outstanding - days payables.
Capex / operating cash flow25.8%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.01Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic-$0.01Net income per basic share, as reported (split-adjusted).
Revenue per share$5.49Revenue / diluted weighted shares.
FCF per share$0.41Free cash flow / diluted weighted shares.
Operating cash flow per share$0.55Cash from operations / diluted weighted shares.
Book value per share$2.83Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$1.03Tangible book value / shares outstanding.
Cash per share$1.60(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$629.6MShare price x shares outstanding.
Enterprise value$512.8MMarket cap + total debt - cash - short-term investments.
P/S1.57xMarket cap / revenue.
P/B3.05xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book8.33xMarket cap / tangible book value, when positive.
P/FCF21.0xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF15.6xMarket cap / cash from operations, when positive.
EV/Sales1.28xEnterprise value / revenue.
EV/EBIT38.7xEnterprise value / operating income, when both are positive.
EV/EBITDA20.3xEnterprise value / EBITDA, when both are positive.
EV/FCF17.1xEnterprise value / free cash flow, when both are positive.
FCF yield4.8%Free cash flow / market cap.
Earnings yield-0.1%Net income / market cap (the inverse of P/E).
What was Cognyte Software Ltd.'s revenue in fiscal 2025?

Cognyte Software Ltd. reported revenue of $400.0M for fiscal 2025, 14.1% higher than the year before.

Was Cognyte Software Ltd. profitable in fiscal 2025?

No. It reported a net loss of $638.0K.

How much free cash flow did Cognyte Software Ltd. generate in fiscal 2025?

Cash from operations of $40.3M minus capital expenditures of $10.4M left free cash flow of $29.9M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Cognyte Software Ltd.